419 related articles for article (PubMed ID: 16627025)
1. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs.
Plotkin LI; Manolagas SC; Bellido T
Bone; 2006 Sep; 39(3):443-52. PubMed ID: 16627025
[TBL] [Abstract][Full Text] [Related]
2. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
Bellido T; Plotkin LI
Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
[TBL] [Abstract][Full Text] [Related]
3. Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis.
Kogianni G; Mann V; Ebetino F; Nuttall M; Nijweide P; Simpson H; Noble B
Life Sci; 2004 Oct; 75(24):2879-95. PubMed ID: 15454340
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
Hussein O; Tiedemann K; Komarova SV
Bone; 2011 Feb; 48(2):202-11. PubMed ID: 20849994
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF
J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503
[TBL] [Abstract][Full Text] [Related]
7. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.
Aguirre JI; Plotkin LI; Stewart SA; Weinstein RS; Parfitt AM; Manolagas SC; Bellido T
J Bone Miner Res; 2006 Apr; 21(4):605-15. PubMed ID: 16598381
[TBL] [Abstract][Full Text] [Related]
8. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an osteocyte-like cell line, MLO-Y4.
Kato Y; Windle JJ; Koop BA; Mundy GR; Bonewald LF
J Bone Miner Res; 1997 Dec; 12(12):2014-23. PubMed ID: 9421234
[TBL] [Abstract][Full Text] [Related]
10. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of bisphosphonates.
Green JR
Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
[TBL] [Abstract][Full Text] [Related]
12. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
[TBL] [Abstract][Full Text] [Related]
13. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
Plotkin LI; Weinstein RS; Parfitt AM; Roberson PK; Manolagas SC; Bellido T
J Clin Invest; 1999 Nov; 104(10):1363-74. PubMed ID: 10562298
[TBL] [Abstract][Full Text] [Related]
14. Zoledronate induces apoptosis in cells from fibro-cellular membrane of unicameral bone cyst (UBC).
Yu J; Chang SS; Suratwala S; Chung WS; Abdelmessieh P; Lee HJ; Yang J; Lee FY
J Orthop Res; 2005 Sep; 23(5):1004-12. PubMed ID: 15921873
[TBL] [Abstract][Full Text] [Related]
15. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
Plotkin LI; Bivi N; Bellido T
Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of osteocyte apoptosis by fluid flow is mediated by nitric oxide.
Tan SD; Bakker AD; Semeins CM; Kuijpers-Jagtman AM; Klein-Nulend J
Biochem Biophys Res Commun; 2008 May; 369(4):1150-4. PubMed ID: 18339304
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of action of bisphosphonates: current status.
Roelofs AJ; Thompson K; Gordon S; Rogers MJ
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6222s-6230s. PubMed ID: 17062705
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation.
Plotkin LI; Aguirre JI; Kousteni S; Manolagas SC; Bellido T
J Biol Chem; 2005 Feb; 280(8):7317-25. PubMed ID: 15590626
[TBL] [Abstract][Full Text] [Related]
19. Is HMGB1 an osteocyte alarmin?
Bidwell JP; Yang J; Robling AG
J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
[TBL] [Abstract][Full Text] [Related]
20. Regulation of apoptosis in osteoclasts and osteoblastic cells.
Xing L; Boyce BF
Biochem Biophys Res Commun; 2005 Mar; 328(3):709-20. PubMed ID: 15694405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
